Genmab A/S (GMAB) Reports Q2 New DARZALEX Sales of $2.88B
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024
July 17, 2024 6:26 AM EDTCompany Announcement
Net sales of DARZALEX® in the second quarter of 2024 totaled USD 2,878 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen)COPENHAGEN, Denmark; July 17, 2024 Genmab A/S (Nasdaq: GMAB) announced today that worldwide... More
